Evidence map›Paper›PMID 33916181›Full record

ArticleMolecules (Basel, Switzerland)2021

An Activatable T

Jongeun Kang, Eunha Hwang, Hyunseung Lee, Mi Young Cho, Sanu Karan, Hak Nam Kim, Jong Seung Kim, Jonathan L Sessler, Sankarprasad Bhuniya, Kwan Soo Hong

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Jongeun KangResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju 28119, Korea.
Eunha HwangCenter for Research Equipment, Korea Basic Science Institute, Cheongju 28119, Korea.
Hyunseung LeeResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju 28119, Korea.
Mi Young ChoResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju 28119, Korea.
Sanu KaranResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju 28119, Korea.
Hak Nam KimCenter for Research Equipment, Korea Basic Science Institute, Cheongju 28119, Korea.
Jong Seung KimDepartment of Chemistry, Korea University, Seoul 02841, Korea.ORCID 0000-0003-3477-1172
Jonathan L SesslerDepartment of Chemistry, The University of Texas at Austin, Austin, TX 78712-1224, USA.
Sankarprasad BhuniyaResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju 28119, Korea.ORCID 0000-0001-5080-0936
Kwan Soo HongResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju 28119, Korea.ORCID 0000-0003-4342-5183
Korea Basic Science Institute · KRChungnam National University · KRCenter for Interdisciplinary Studies · INKorea University · KRThe University of Texas at Austin · US

Funding

National Research Council of Science and Technology (NST) grant from the Korea government (MSIT) CAP-18-02-KRIBBNational Research Foundation of Korea 2020R1A2C2012011Welch Foundation F-0018
6 · The paper itself

Abstract

We have synthesized new magnetic resonance imaging (MRI) T

Indexed as

Contrast MediaMagnetic Resonance SpectroscopySulfhydryl CompoundsThioredoxinsCell Line, TumorCell TrackingHumansPhantoms, ImagingContrast MediaSulfhydryl CompoundsThioredoxinsactivatable contrastMR relaxivitythioredoxinvicinal thiols

Identifiers

PMID33916181
PMCPMC8037249
OpenAlexW3145605157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.